wy 48252 has been researched along with ovalbumin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auen, MA; Chang, J; Hand, JM; Kreft, AF; Musser, JH; Schwalm, SF | 1 |
1 other study(ies) available for wy 48252 and ovalbumin
Article | Year |
---|---|
Wy-48,252 (1,1,1-trifluoro-N-[3-(2-quinolinylmethoxy)phenyl]methane sulfonamide) an orally active leukotriene D4 antagonist: pharmacological characterization in vitro and in vivo in the guinea pig.
Topics: Animals; Bronchi; Capillary Permeability; Cysteine; Guinea Pigs; Histamine; Hydroxyquinolines; In Vitro Techniques; Indomethacin; Male; Muscle Contraction; Muscle, Smooth; Ovalbumin; SRS-A; Trachea | 1989 |